Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-043632
Filing Date
2024-10-24
Accepted
2024-10-24 16:26:01
Documents
1
Period of Report
2024-10-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1729801556.html 4  
1 FORM 4 wk-form4_1729801556.xml 4 10075
  Complete submission text file 0001628280-24-043632.txt   11564
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
SCANGOS GEORGE A (Reporting) CIK: 0001202102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 241392973

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)